Sort by
Refine Your Search
-
Category
-
Field
-
for a highly motivated and team-science minded Postdoctoral Fellow, to study the molecular mechanisms involved in regulating functional beta cell mass, skeletal muscle insulin action, whole body glucose
-
of the Division of Epigenetics and Transcriptional Engineering at City of Hope Cancer Center. His lab investigates epigenetic mechanisms of drug resistance and identifies therapeutic targets in various
-
working on projects that aim to develop novel therapeutics for cancer. The successful candidate will perform experiments to investigate the activity and mechanism of action of new anti-cancer agents in
-
at the Beckman Research Institute of City of Hope. This position is to participate in NIH-funded research on the mechanisms responsible for regulating T cell activation and differentiation. Fellows in this lab
-
operation of mechanical systems, monitoring systems, and equipment. Coordinate preventative maintenance and maintain cGMP compliance for building systems and major process equipment. Conduct internal cGMP and
-
, shaping the future of medicine through cutting-edge research. Join Dr. Marcel van den Brink’s multidisciplinary team to explore innovative ways to decipher the molecular mechanisms of thymic regeneration
-
have discovered a novel immune-mediated mechanism that contributes to the development of early-onset colorectal cancer and are investigating the epigenetic and transcriptional regulation of this pathway
-
have discovered a novel immune-mediated mechanism that contributes to the development of early-onset colorectal cancer and are investigating the epigenetic and transcriptional regulation of this pathway
-
have been focused on exploring the molecular mechanisms of leukemogenesis and evolution, discovery of novel therapeutic targets, and development of novel therapeutic strategies, including novel
-
on drug development and discovery of basic mechanisms and novel therapeutic targets of leukemogenesis, and genetic and epigenetic prognostic biomarkers in acute myeloid leukemia (AML). We conduct research